KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Goodwill & Intangibles (2018 - 2025)

Historic Goodwill & Intangibles for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to $3.9 million.

  • Aurinia Pharmaceuticals' Goodwill & Intangibles fell 1348.41% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 1348.41%. This contributed to the annual value of $4.4 million for FY2024, which is 1249.75% down from last year.
  • As of Q3 2025, Aurinia Pharmaceuticals' Goodwill & Intangibles stood at $3.9 million, which was down 1348.41% from $4.0 million recorded in Q2 2025.
  • Aurinia Pharmaceuticals' Goodwill & Intangibles' 5-year high stood at $9.9 million during Q1 2021, with a 5-year trough of $3.9 million in Q3 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' median Goodwill & Intangibles value was $5.7 million (recorded in 2023), while the average stood at $6.2 million.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first tumbled by 995.98% in 2021, then plummeted by 2354.83% in 2022.
  • Quarter analysis of 5 years shows Aurinia Pharmaceuticals' Goodwill & Intangibles stood at $8.4 million in 2021, then fell by 23.55% to $6.4 million in 2022, then decreased by 22.54% to $5.0 million in 2023, then fell by 12.5% to $4.4 million in 2024, then decreased by 10.42% to $3.9 million in 2025.
  • Its last three reported values are $3.9 million in Q3 2025, $4.0 million for Q2 2025, and $4.2 million during Q1 2025.